Picture EBD Group ChinaBio Partnering Forum 2022 650x100

News > All

Total search results: 9295 | Ordered by Date (descending)
1 2 3 ... 91 92 93  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. 2022-09-22
Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. 2022-09-21
Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". 2022-09-21
Scitara Corporation. (9/20/22). "Press Release: Scitara Announces Partnership with Agilent to Benefit Customers with Enhanced Digital Lab Connectivity". Marlborough, MA. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
CytoReason Ltd.. (9/20/22). "Press Release: CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development". Tel Aviv. 2022-09-20
Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". 2022-09-19
Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. 2022-09-15
Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA. 2022-09-14
SparingVision S.A.S.. (9/14/22). "Press Release: SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases". 2022-09-14
Pretzel Therapeutics. (9/12/22). "Press Release: Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies". Waltham, MA. 2022-09-12
Novo Nordisk A/S. (9/12/22). "Press Release: Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence". Bagsvćrd & Redmond, WA. 2022-09-12
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. 2022-09-09
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. 2022-09-08
genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. 2022-09-08
MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY. 2022-09-08
Lesaffre & Cie.. (9/7/22). "Press Release: Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-throughput Genome Editing and Synthetic Biology". Paris & San Francisco, CA. 2022-09-07
Arsenal Biosciences, Inc.. (9/6/22). "Press Release: Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development". South San Francisco, CA. 2022-09-06
Bicycle Therapeutics plc. (9/6/22). "Press Release: Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference". Cambridge & Boston, MA. 2022-09-06
ADC Therapeutics S.A.. (9/6/22). "Press Release: ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference". Lausanne. 2022-09-06
Pleco Therapeutics B.V.. (9/6/22). "Press Release: Pleco Therapeutics Announces Final Close of Its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU". Nijmegen. 2022-09-06
Boehringer Ingelheim. (9/2/22). "Press Release: U.S. FDA Approves First Treatment Option for Generalized Pustular Psoriasis Flares in Adults". Ingelheim. 2022-09-02
Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris. 2022-09-02
BioEcho Life Sciences GmbH. (9/2/22). "Press Release: BioEcho Life Sciences Announces Expansion with New US Subsidiary". Cologne. 2022-09-02
Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel. 2022-09-01
Agilent Technologies Inc.. (9/1/22). "Press Release: Agilent Collaborates with Mettler Toledo to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results". Santa Clara, CA. 2022-09-01
The Protein Brewery B.V.. (9/1/22). "Press Release: The Protein Brewery Appoints Sue Garfitt as CEO". Breda. 2022-09-01
Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. 2022-09-01
Novo Nordisk A/S. (9/1/22). "Press Release: Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders". Bagsvćrd & Watertown, MA. 2022-09-01
Centogene N.V.. (9/1/22). "Press Release: Centogene to Present at Upcoming Investor & Partnering Conferences in September". Cambridge, MA, Rostock & Berlin. 2022-09-01
Ginkgo Bioworks Inc.. (9/1/22). "Press Release: Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing and Life Science Tools". Boston, MA. 2022-09-01
BioNTech SE. (9/1/22). "Press Release: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union". New York, NY & Mainz. 2022-09-01
AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal. 2022-09-01
CRISPR Therapeutics AG. (8/31/22). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA. 2022-08-31
BioNTech SE. (8/31/22). "Press Release: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older". New York, NY & Mainz. 2022-08-31
MorphoSys AG. (8/31/22). "Press Release: MorphoSys Appoints Tim Demuth as New Chief Research and Development Officer, Following the Retirement of Malte Peters". Planegg. 2022-08-31
Ori Biotech Ltd.. (8/30/22). "Press Release: Ori Biotech Adds to Senior Team, Scientific Advisory Board and Expands Global Footprint". London. 2022-08-30
Moderna, Inc.. (8/26/22). "Press Release: Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform". Cambridge, MA. 2022-08-26
Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel. 2022-08-25
ElevateBio, LLC. (8/25/22). "Press Release: ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene Therapy Innovation". Pittsburgh, PA. 2022-08-25
eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. 2022-08-23
ElevateBio, LLC. (8/23/22). "Press Release: ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines". Waltham, MA. 2022-08-23
Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. 2022-08-23
Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel. 2022-08-22
Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". 2022-08-22
Ampersand Capital Partners. (8/22/22). "Press Release: Ampersand Closes Oversubscribed Fund at $1.2 Billion Hard Cap". Wellesley, MA. 2022-08-22
SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". 2022-08-22
BioNTech SE. (8/22/22). "Press Release: Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine". New York, NY & Mainz. 2022-08-22
Ginkgo Bioworks Inc.. (8/19/22). "Press Release: Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets". Boston, MA. 2022-08-19
Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. 2022-08-18
Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA. 2022-08-18
Moderna, Inc.. (8/17/22). "Press Release: James Mock Joins Moderna as Chief Financial Officer". Cambridge, MA. 2022-08-17
Eurobio Scientific S.A.. (8/17/22). "Press Release: Eurobio Scientific Signs an Agreement to Acquire GenDx, International HLA Diagnostics Specialist". Paris. 2022-08-17
ChemDiv, Inc.. (8/11/22). "Press Release: ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery". San Diego, CA & Bremen. 2022-08-11
Vector BioPharma AG. (8/10/22). "Press Release: Versant Ventures Launches Vector BioPharma AG". Basel. 2022-08-10
Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX. 2022-08-09
Navis Capital Partners. (8/9/22). "Press Release: Navis Capital Partners Announces the Sale of 100% of B Medical Systems to Azenta, Inc". Singapore. 2022-08-09
Global Blood Therapeutics, Inc.. (8/8/22). "Press Release: Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology". New York, NY & South San Francisco, CA. 2022-08-08
BioNTech SE. (8/8/22). "Press Release: BioNTech Announces Second Quarter Financial Results and Corporate Update". Mainz. 2022-08-08
Valneva S.E.. (8/8/22). "Press Release: Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15". New York, NY & Saint-Herblain. 2022-08-08
Azenta, Inc.. (8/8/22). "Press Release: Azenta Announces Agreement to Acquire B Medical Systems". Chelmsford, MA. 2022-08-08
BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. 2022-08-05
ElevateBio, LLC. (8/4/22). "Press Release: ElevateBio Announces the Formation of a New Company with George Daley, M.D., Ph.D., and Boston Children’s Hospital to Develop iPSC-Derived Allogeneic Immune Therapies". Waltham, MA. 2022-08-04
Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA. 2022-08-04
Roslin Cell Therapies Ltd. (RoslinCT). (8/4/22). "Press Release: RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO". Edinburgh & Hopkinton, MA. 2022-08-04
Wyss Institute for Biologically Inspired Engineering at Harvard University. (8/4/22). "Press Release: 3EO Health Licenses Wyss Institute Technology from Harvard, Aiming to Develop At-home Molecular Testing with PCR-grade Sensitivity and Antigen Test-leve 2022-08-04
F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. 2022-08-04
Congenica Ltd.. (8/4/22). "Press Release: GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution". Cambridge & Cleveland, OH. 2022-08-04
MiroBio Ltd.. (8/4/22). "Press Release: Gilead Sciences to Acquire MiroBio". Foster City, CA & Oxford. 2022-08-04
Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. 2022-08-03
Pfizer Inc.. (8/3/22). "Press Release: Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy". New York, NY. 2022-08-03
Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA. 2022-08-03
Bio-Rad Laboratories, Inc.. (8/3/22). "Press Release: Bio-Rad Acquires Curiosity Diagnostics". Hercules, CA. 2022-08-03
Sosei Group Corporation (d/b/a Sosei Heptares). (8/2/22). "Press Release: Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases". Tokyo & Cambridge. 2022-08-02
S-Biomedic N.V.. (8/2/22). "Press Release: S-Biomedic Welcomes Pascal Yvon to Lead Its B2B Commercial Activities". Beerse. 2022-08-02
Eleven Therapeutics. (8/2/22). "Press Release: Eleven Therapeutics Announces $22 Million in Seed Funding. Round Includes $9 Million from the Bill & Melinda Gates Foundation". Tel Aviv & Cambridge. 2022-08-02
MDxHealth S.A.. (8/2/22). "Press Release: MDxHealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results". Irvine, CA & Herstal. 2022-08-02
ResMed Inc.. (8/2/22). "Press Release: ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio". Martinsried & Leipzig. 2022-08-02
Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY. 2022-07-28
Ryvu Therapeutics S.A.. (7/26/22). "Press Release: Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board". Kraków. 2022-07-26
Replay Holdings LLC. (7/25/22). "Press Release: Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA". San Diego, CA & London. 2022-07-25
Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo to Acquire Zymergen. Acquisition Is Expected to Accelerate the Development of Ginkgo's Innovative Horizontal Synthetic Biology Platform". Boston, MA & Emeryville, CA. 2022-07-25
NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea 2022-07-25
NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich. 2022-07-25
Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities". Boston, MA. 2022-07-25
Amazon. (7/21/22). "Press Release: Amazon and One Medical Sign an Agreement for Amazon to Acquire One Medical". Seattle, WA & San Francisco, CA. 2022-07-21
Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne. 2022-07-21
Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. 2022-07-21
Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Hřngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. 2022-07-20
Immunocore Holdings plc. (7/18/22). "Press Release: Immunocore Announces $140 Million Private Placement Financing". Oxfordshire, Conshohocken, PA & Rockville, MD. 2022-07-18
Oxford Science Park, The. (7/18/22). "Press Release: The Oxford Science Park Agrees to Sale of Development Site to the Lawrence J. Ellison Institute for Transformative Medicine". Oxford. 2022-07-18
Delfi Diagnostics, Inc.. (7/18/22). "Press Release: Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests". Baltimore, MD & Palo Alto, CA. 2022-07-18
Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. 2022-07-18
Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris. 2022-07-18
Rubius Therapeutics, Inc.. (7/14/22). "Press Release: Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors". Cambridge, MA. 2022-07-14
Manifold Biotechnologies, Inc.. (7/14/22). "Press Release: Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform". Boston, MA. 2022-07-14
IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried. 2022-07-14
BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. 2022-07-13
Agomab Therapeutics N.V.. (7/13/22). "Press Release: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million". Ghent. 2022-07-13
Delfi Diagnostics, Inc.. (7/12/22). "Press Release: Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer". Baltimore, MD. 2022-07-12
1 2 3 ... 91 92 93  next pagenext page


Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BioPharm Amercia 2022 Boston 650x300px

» top